Radient Technologies Inc (RDDTF)
0.00
USD |
OTCM |
May 21, 16:00
Radient Technologies Total Liabilities (Quarterly): 31.69M for Dec. 31, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 31.69M |
September 30, 2022 | 30.53M |
June 30, 2022 | 30.79M |
March 31, 2022 | 30.33M |
December 31, 2021 | 28.78M |
September 30, 2021 | 27.08M |
June 30, 2021 | 26.53M |
March 31, 2021 | 25.21M |
December 31, 2020 | 32.19M |
September 30, 2020 | 29.32M |
June 30, 2020 | 27.74M |
March 31, 2020 | 27.44M |
December 31, 2019 | 30.32M |
September 30, 2019 | 26.76M |
June 30, 2019 | 26.45M |
March 31, 2019 | 7.627M |
December 31, 2018 | 7.269M |
September 30, 2018 | 7.248M |
June 30, 2018 | 7.418M |
March 31, 2018 | 3.206M |
December 31, 2017 | 3.123M |
September 30, 2017 | 6.812M |
Date | Value |
---|---|
June 30, 2017 | 8.198M |
March 31, 2017 | 8.032M |
December 31, 2016 | 7.651M |
September 30, 2016 | 8.713M |
June 30, 2016 | 8.939M |
March 31, 2016 | 8.766M |
December 31, 2015 | 7.507M |
September 30, 2015 | 7.640M |
June 30, 2015 | 7.522M |
March 31, 2015 | 7.016M |
December 31, 2014 | 7.350M |
September 30, 2014 | 7.455M |
June 30, 2014 | 8.415M |
December 31, 2013 | 0.0487M |
September 30, 2013 | 0.0087M |
June 30, 2013 | 0.0032M |
March 31, 2013 | 0.0045M |
December 31, 2012 | 0.0091M |
September 30, 2012 | 0.0042M |
June 30, 2012 | 0.0024M |
March 31, 2012 | 0.013M |
September 30, 2011 | 0.0279M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.21M
Minimum
Mar 2021
32.19M
Maximum
Dec 2020
28.74M
Average
28.78M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 11.50M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Lexaria Bioscience Corp | 0.2042M |
Liminal Biosciences Inc (DELISTED) | 7.790M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 20.63M |
Shareholders Equity (Quarterly) | -11.06M |